SCHEMBL7415500

SCHEMBL7415500

[CH2]c1cc(C(C)NC)ccc1Cl

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39
KCNH2 Q12809 10/20 0.36
SLC6A4 P31645 9/20 0.36
HTR2A P28223 5/20 0.36
SLC6A2 P23975 4/20 0.32
SLC6A3 Q01959 4/20 0.32
NEK1 Q96PY6 2/20 0.32
CYP1A2 P05177 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
CYP2D6 P10635 3/20 0.31
PARP1 P09874 1/20 0.31
CYP3A4 P08684 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13267449 0.82 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2LMNAHTTKCNH2
SCHEMBL178624 0.82 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2LMNAHTTKCNH2
SCHEMBL13076693 0.78 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2LMNAHTTKCNH2
SCHEMBL9070740 0.78 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2LMNAHTTKCNH2
SCHEMBL178483 0.78 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2LMNAHTTKCNH2
SCHEMBL10087245 0.77 GPR139 (0.40) ALDH1A1SMN1; SMN2LMNAHTTKCNH2
SCHEMBL8284254 0.74 CYP3A4 (0.42) ALDH1A1SMN1; SMN2LMNAHTTKCNH2
SCHEMBL178506 0.73 SLC6A4 (0.47) ALDH1A1SMN1; SMN2LMNAHTTKCNH2
SCHEMBL15419067 0.73 SLC6A4 (0.47) ALDH1A1SMN1; SMN2LMNAHTTKCNH2
SCHEMBL2668984 0.70 TAS1R3 (0.49) ALDH1A1SMN1; SMN2LMNAKCNH2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177177-A1 SUBSTITUTED 4-OXO-QUINOLINE-3-CARBOXAMIDES: GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 2002-02-06 EP disclosed
WO-2000068202-A1 SUBSTITUTED 4-OXO-QUINOLINE-3-CARBOXAMIDES: GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 2000-11-16 WO disclosed